TransMedics Group, Inc.

Historical 13F Holders

Symbol
TMDX
CUSIP
89377M109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 89377M109 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
15.0% 5/12/2025
Event 3/31/2025
BlackRock, Inc. 13G/A 14.6% 7/18/2025
Event 6/30/2025
Vanguard Portfolio Management LLC 13G 5.7% 4/29/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.1% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 33 923 k $77.1 M
2026 Q2 404 37.5 M $2.35 B
2026 Q1 438 36.5 M $3.63 B
2025 Q4 455 37.2 M $4.53 B
2025 Q3 424 37.6 M $4.21 B
2025 Q2 401 37.2 M $4.98 B
2025 Q1 325 39.1 M $2.63 B
2024 Q4 342 38.5 M $2.40 B
2024 Q3 403 36.9 M $5.77 B
2024 Q2 368 35.1 M $5.29 B
2024 Q1 288 35.4 M $2.61 B
2023 Q4 267 37.1 M $2.93 B
2023 Q3 242 35.6 M $1.95 B
2023 Q2 260 34.4 M $2.89 B
2023 Q1 243 31.8 M $2.41 B
2022 Q4 213 30.9 M $1.91 B
2022 Q3 195 28.6 M $1.20 B
2022 Q2 140 23.2 M $730 M
2022 Q1 117 21.2 M $571 M
2021 Q4 131 20.1 M $385 M
2021 Q3 131 19.2 M $637 M
2021 Q2 138 19.2 M $636 M
2021 Q1 116 18.7 M $775 M
2020 Q4 76 21.4 M $425 M
2020 Q3 75 20.8 M $287 M
2020 Q2 73 20.8 M $373 M
2020 Q1 58 15.3 M $185 M
2019 Q4 65 15.3 M $291 M
2019 Q3 52 14.5 M $342 M
2019 Q2 66 14.0 M $393 M
2019 Q1 1 54.0 $2.00 k